Front. Cardiovasc. Med. Frontiers in Cardiovascular Medicine Front. Cardiovasc. Med. 2297-055X Frontiers Media S.A. 10.3389/fcvm.2026.1776023 Correction Correction: Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma XieHuanglie 1Writing – original draftInvestigation ZhangKe 2Writing – original draft HanPengyu 1ConceptualizationWriting – review & editing ZhengChaoyang 1 *SupervisionWriting – review & editing The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China Correspondence: Chaoyang Zheng zhengchaoyang2233@163.com 26022026 2026 131776023 26122025 09012026 29012026 © 2026 Xie, Zhang, Han and Zheng. 2026Xie, Zhang, Han and Zhenghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma Xie H, Zhang K, Hang P and Zheng C (2025). Front. Cardiovasc. Med. 12:1672655. doi: 10.3389/fcvm.2025.1672655 acute myocardial infarction differential diagnosis electrocardiogram pericardial metastasis urachal carcinoma Guangdong Provincial Hospital of Traditional Chinese Medicine10.13039/100012829YN2022QN28YN2022MS08 section-at-acceptanceCardio-Oncology

An incorrect number was provided for the Guangdong Provincial Hospital of Traditional Chinese Medicine's Special Research Fund for Traditional Chinese Medicine Science and Technology. The correct numbers are YN2022QN28 and YN2022MS08.

The footnote “1C225: Cetuximab; FOLFOX regimen: Folinic acid (FOL) + Fluorouracil (F) + Oxaliplatin (OX); BEV: Bevacizumab; FOLFIRI regimen: Folinic acid (FOL) + Fluorouracil (F) + Irinotecan (IRI)” has been removed.

Author Pengyu Han was erroneously spelled as Pengyu Hang.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland